What is the difference between P-21 Peptide and SS-31?

P-21 Peptide: Short neuropeptide based on the activity-dependent neurotrophic factor (ADNF) family with potent neuroprotective effects demonstrated in Alzheimer's disease models. Distinct from the cell cycle inhibitor protein p21/CDKN1A. Reduces amyloid-beta burden, improves cognitive outcomes in rodent models, and modulates neuroinflammation through STAT3 and JAK2 signaling pathways. SS-31: SS-31 (Elamipretide) is a mitochondria-targeted peptide that concentrates in the inner mitochondrial membrane, protecting cardiolipin and restoring mitochondrial function. It is being studied for heart failure, aging, and metabolic disease. One of the most exciting longevity-adjacent peptides in current research. Both are in the Anti-Aging & Longevity category but differ in mechanism, dosing, and research evidence — see the full comparison.

Can you take P-21 Peptide and SS-31 together?

There is no specific, well-documented interaction rule for combining P-21 Peptide and SS-31 in the aggregated research reviewed. Combining peptides should only be considered under professional supervision. This is not medical advice.

Which is better researched, P-21 Peptide or SS-31?

P-21 Peptide is currently preclinical only and SS-31 is investigational (in trials). "Better researched" depends on your research goal — review each profile's cited sources.

Anti-Aging & Longevity · Comparison

P-21 Peptide vs SS-31

A neutral, side-by-side comparison of two anti-aging & longevity peptides — their mechanisms, dosing ranges, administration routes, side effects, and research evidence. For research and educational purposes only.

P-21 Peptide

Preclinical only

Short neuropeptide based on the activity-dependent neurotrophic factor (ADNF) family with potent neuroprotective effects demonstrated in Alzheimer's disease models. Distinct from the cell cycle inhibitor protein p21/CDKN1A. Reduces amyloid-beta burden, improves cognitive outcomes in rodent models, and modulates neuroinflammation through STAT3 and JAK2 signaling pathways.

Full profile

SS-31

Investigational (in trials)

SS-31 (Elamipretide) is a mitochondria-targeted peptide that concentrates in the inner mitochondrial membrane, protecting cardiolipin and restoring mitochondrial function. It is being studied for heart failure, aging, and metabolic disease. One of the most exciting longevity-adjacent peptides in current research.

Full profile

	P-21 Peptide	SS-31
Category	Anti-Aging & Longevity	Anti-Aging & Longevity
Also known as	P21, Colivelin fragment, P21 neuropeptide, ADNF-related neuropeptide	Elamipretide, MTP-131, Bendavia, Szeto-Schiller peptide 31
Evidence	Preclinical only	Investigational (in trials)
Dosing range	5mcg–20mcg mcg, daily or every other day (intranasal or SC)	1mg–10mg mg, daily or every other day
Administration	Intranasal, Subcutaneous injection	Subcutaneous injection, Intravenous (clinical trials)
Key side effects	Limited human safety data, In animal studies: well-tolerated at therapeutic doses, Theoretical STAT3 pathway concerns with chronic use (pro-survival signaling), Nasal irritation (intranasal route)	Injection site reactions, Nausea (rare), Generally well-tolerated in clinical trial populations
Cited sources	2 references	2 references

Key differences

Evidence level differs: P-21 Peptide is preclinical only, while SS-31 is investigational (in trials).
Administration: P-21 Peptide — Intranasal, Subcutaneous injection; SS-31 — Subcutaneous injection, Intravenous (clinical trials).
Dosing units differ: P-21 Peptide is dosed in mcg, SS-31 in mg — they operate at different scales.
Frequency: P-21 Peptide is typically daily or every other day (intranasal or SC); SS-31 is daily or every other day.

How each works

P-21 Peptide

P-21 activates STAT3/JAK2 signaling through CNTF-related pathways, reducing amyloid-beta toxicity by activating amyloid-clearing enzymes (insulin-degrading enzyme, neprilysin) and inhibiting tau phosphorylation. Derived from the colivelin family of neuroprotective peptides, P-21 demonstrates cognitive improvement in Alzheimer's mouse models at doses far below cytotoxic levels. Human data remains limited.

SS-31

SS-31 selectively accumulates in mitochondria and binds cardiolipin — a phospholipid critical for the electron transport chain. By stabilizing cardiolipin, SS-31 restores ATP production, reduces reactive oxygen species (ROS), and prevents mitochondrial permeability transition. Animal studies show dramatic reversal of mitochondrial dysfunction in aged tissues.

Read the full P-21 Peptide profile Read the full SS-31 profile

This comparison aggregates public research and structured profile data for informational purposes only. It is not medical advice and does not recommend either compound for human use. Consult a qualified healthcare provider before considering any peptide.